Published in Tumour Biol on January 18, 2012
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol (2012) 2.07
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol (2013) 1.95
How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Expert Rev Mol Diagn (2012) 1.66
Ogino et Al. Respond to "the 21st century epidemiologist". Am J Epidemiol (2012) 0.79
Synaptopodin-2 induces assembly of peripheral actin bundles and immature focal adhesions to promote lamellipodia formation and prostate cancer cell migration. Oncotarget (2015) 0.76
Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma. J Invest Dermatol (2015) 0.75
Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer. Oncogenesis (2017) 0.75
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res (2003) 1.46
Histerocystoplasty: a novel surgical procedure in the rat. J Surg Res (2011) 1.44
Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients. Tumour Biol (2012) 1.42
Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med (2010) 1.34
miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol (2012) 1.34
Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics (2009) 1.24
Cytologic features of pheochromocytoma and retroperitoneal paraganglioma: a morphologic and immunohistochemical study of 13 cases. Acta Cytol (2006) 1.16
Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease. PLoS One (2012) 1.09
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J Proteome Res (2007) 1.03
Galectin-3 expression is associated with bladder cancer progression and clinical outcome. Tumour Biol (2010) 1.01
Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res (2009) 1.00
Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J Clin Endocrinol Metab (2008) 1.00
Differential protein expression profiling by iTRAQ-two-dimensional LC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor KiSS-1 gene. Mol Cell Proteomics (2010) 0.96
Contribution of recombination and selection to molecular evolution of Citrus tristeza virus. J Gen Virol (2009) 0.93
Serum level of fibroblast growth factor 23 in maintenance renal transplant patients. Nephrol Dial Transplant (2012) 0.91
KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer. Tumour Biol (2012) 0.91
Multiplexed methylation profiles of tumor suppressor genes in bladder cancer. J Mol Diagn (2010) 0.91
Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab. Clin Colorectal Cancer (2013) 0.90
KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients. Am J Pathol (2011) 0.89
Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis. Anticancer Res (2009) 0.88
Identification of PMF1 methylation in association with bladder cancer progression. Clin Cancer Res (2008) 0.88
Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C. PLoS One (2013) 0.87
Urine epigenomics: a promising path for bladder cancer diagnostics. Expert Rev Mol Diagn (2012) 0.87
Telomerase activity as a prognostic factor in colorectal cancer. Onkologie (2005) 0.87
Fine needle aspiration cytology of endocrine neoplasms of the pancreas. Morphologic and immunocytochemical findings in 20 cases. Acta Cytol (2004) 0.87
Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study. J Urol (2013) 0.87
[Physiopathology of the infertile testicle. Etiopathogenesis of varicocele]. Arch Esp Urol (2004) 0.86
Myopodin methylation is associated with clinical outcome in patients with T1G3 bladder cancer. J Urol (2010) 0.86
PCPH expression is an early event in the development of testicular germ cell tumors. Int J Oncol (2006) 0.85
Circulating tumour cells in locally advanced breast cancer. Clin Transl Oncol (2009) 0.85
Cystic dysplasia of the epididymis: a disorder of mesonephric differentiation associated with renal maldevelopment. Virchows Arch (2010) 0.84
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA. J Transl Med (2013) 0.83
A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells. Am J Pathol (2013) 0.82
A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness. PLoS One (2013) 0.82
Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients? Pharmacogenomics (2014) 0.82
Circulating tumoral cells lack circadian-rhythm in hospitalized metastasic breast cancer patients. Clin Transl Oncol (2006) 0.80
Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors. Tumour Biol (2014) 0.80
[Unilateral essential hematuria: diagnosis, endoscopic treatment, and new diagnostic-therapeutic algorithm]. Arch Esp Urol (2007) 0.79
Polyamine-modulated factor-1 methylation predicts Bacillus Calmette-Guérin response in patients with high-grade non-muscle-invasive bladder carcinoma. Eur Urol (2012) 0.79
Effect of β-catenin alterations in the prognosis of patients with sporadic colorectal cancer. J Cancer Res Ther (2014) 0.78
Fine-needle aspiration cytology of extranodal natural killer/T-cell lymphoma. Diagn Cytopathol (2002) 0.78
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis. Arthritis Res Ther (2014) 0.78
Immunodetection of inhibin in the human testis and epididymis during normal development and in non-tumoural testicular lesions. Reprod Fertil Dev (2010) 0.78
Cytologic features of round cell liposarcoma: a report on five patients. Cancer (2003) 0.78
Endoureterotomy by intraluminal invagination for nonmalignant ureterointestinal anastomotic strictures: description of a new surgical technique and long-term followup. J Urol (2005) 0.78
Inhibin bodies: a new marker for immature Sertoli cells. Histopathology (2011) 0.76
Cytologic features of clear cell carcinoma of the female genital tract. Diagnostic value of the "raspberry body" in nonexfoliative cytologic specimens. Acta Cytol (2004) 0.76
Perspectives in pediatric pathology, chapter 3. Testicular development from birth to puberty: systematic evaluation of the prepubertal testis. Pediatr Dev Pathol (2014) 0.76
Cytologic features of metanephric adenoma of the kidney. Cytojournal (2009) 0.76
Spontaneous infarction in fibroadenoma. Diagn Cytopathol (2003) 0.75
Diagnosis of chondroid lipoma by fine-needle aspiration biopsy. Arch Pathol Lab Med (2002) 0.75
[The use of laser technology for the treatment of ureterointestinal stenosis]. Arch Esp Urol (2008) 0.75
Perspectives in pediatric pathology, chapter 4. Pubertal and adult testis. Pediatr Dev Pathol (2015) 0.75
[Is there a risk of carcinoma dissemination in the percutaneous access for endoscopical treatment of upper urinary tract urothelial tumors?]. Arch Esp Urol (2004) 0.75
Prognostic value of tissue-polypeptide specific antigen (TPS) in bladder cancer. Anticancer Res (2003) 0.75
A9 region in EPHB2 mutation is frequent in tumors with microsatellite instability. Analysis of prognosis. Anticancer Res (2013) 0.75
Fine needle aspiration cytology of solid papillary carcinoma of the breast. A report of four cases. Acta Cytol (2003) 0.75
Perspectives in pediatric pathology, chapter 1. Normal development of testicular structures: from the bipotential gonad to the fetal testis. Pediatr Dev Pathol (2014) 0.75
Paratesticular cysts with benign epithelial proliferations of wolffian origin. Am J Clin Pathol (2005) 0.75
Testicular albuginea neurofibroma: findings at ultrasonography and magnetic resonance imaging with pathological correlation. Arch Esp Urol (2009) 0.75
Fine-needle aspiration cytology of mammary myofibroblastoma: a report of six cases. Acta Cytol (2012) 0.75
Bladder autoaugmentation with protective autologous uterine flap. Experimental study in the rat. Int J Surg (2013) 0.75
[Pathologic classification of upper urinary tract tumors]. Arch Esp Urol (2004) 0.75
Cytologic features of alveolar soft part sarcoma: report of three cases. Diagn Cytopathol (2002) 0.75
[Upper urinary tract tumors pathology (ureter, pelvis and renal calyces)]. Arch Esp Urol (2004) 0.75
[Update of the WHO classification of tumors of the upper urothelium]. Arch Esp Urol (2005) 0.75
Diagnostic value of differential quantification of spermatids in obstructive azoospermia. J Androl (2003) 0.75
Fine needle aspiration of toxoplasmic (Piringer-Kuchinka) lymphadenitis: a cytohistologic correlation study. Acta Cytol (2005) 0.75
Perspectives in pediatric pathology: chapter 2. Testicular descent. Pediatr Dev Pathol (2014) 0.75